|3.||B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
|5.||Non-Hodgkin Lymphoma (Lymphosarcoma)
|1.||Itakura, Asako: 1 article (05/2013)|
|2.||Lanzer, Kathleen G: 1 article (05/2013)|
|3.||Freeman, Michael L: 1 article (05/2013)|
|4.||Roberts, Alan D: 1 article (05/2013)|
|5.||Burkum, Claire E: 1 article (05/2013)|
|6.||Pinkevych, Mykola: 1 article (05/2013)|
|7.||Blackman, Marcia A: 1 article (05/2013)|
|8.||Szaba, Frank M: 1 article (05/2013)|
|9.||Woodland, David L: 1 article (05/2013)|
|10.||McCarty, Owen J T: 1 article (05/2013)|
05/01/1994 - "Monoclonal immunoglobulin deposition disease, a complication of overtly malignant or apparently benign immunoproliferative disorders, is a severe disease featuring tissue deposition of monoclonal light, light and heavy, or heavy chains. "
11/01/1993 - "The factors that might contribute to the formation of corneal crystalloidal deposits in immunoproliferative disorders are discussed, and include: 1) an inherent propensity for crystallization of some immunoglobulins or kappa-light chains, perhaps because of abnormal molecular structure; and 2) local factors in the cornea that might promote deposition and crystallization of immunoprotein, such as temperature, pH, the water content, and extracellular matrix components."
05/01/1992 - "Structurally abnormal immunoglobulins in human immunoproliferative disorders."
10/07/1985 - "Data relative to other immunoproliferative disorders are consistent with the hypothesis that the immunoglobulins play a key role in the regulation of the multiplication of lymphocytic cells."
02/01/1993 - "Heavy chain diseases (HCD) are immunoproliferative disorders characterized by the production of monoclonal immunoglobulin molecules composed of deleted heavy chains devoid of light chains. "
|2.||Immunoglobulin G (IgG)IBA
01/01/1977 - "Most of the bone marrow lymphocytes had membrane IgG. This case represents an intermediate form between myeloma and Waldenström's disease, thus supporting the unitarian concept of all the immunoproliferative disorders."
01/01/1986 - "Unstimulated peripheral blood mononuclear cells from patients with angiocentric T cell immunoproliferative disorders and concanavalin A-stimulated normal peripheral blood mononuclear cells secrete a phagocytosis-inducing factor (PIF) that induces a fivefold to 50-fold enhancement of phagocytosis of IgG-coated ox red blood cells by U937 cells. "
01/01/1977 - "A case of immunoproliferative disorder with clinical features of Waldenström's disease but with an IgG-k instead of IgM serum M component is described. "
|3.||Immunoglobulin D (IgD)IBA
01/01/1982 - "An immunoproliferative disorder with M component IgD/lambda and a strong decrease of the other Ig classes in the serum is reported. "
01/01/1982 - "Monoclonal immunoproliferative disorder of B-lymphocytes IgD/lambda changing from chronic lymphocytic leukaemia to myeloma and plasmacytic leukaemia pattern."
01/01/1974 - "Surface IgD in immunoproliferative disorders."
03/01/1985 - "Chronic antigenic stimulation by asbestos could predispose one to the immunoproliferative disorders seen in these patients. "
02/15/1981 - "Chronic antigenic stimulation by asbestos could predispose one to the immunoproliferative disorder seen in this patient or be responsible for it. "
|5.||Muromonab-CD3 (Muromonab CD3)FDA Link
09/01/1987 - "Three groups of patients with immunoproliferative disorders (15 multiple myeloma, 11 non-Hodgkin's lymphoma, 21 chronic lymphocytic leukemia) were studied by immunological characterization and compared to a group of 20 normal subjects (controls) using anti-immunoglobulin coated polyacrylamide beads (T-B Quantigen test, QT), erythrocyte rosettes (ER), surface immunoglobulin (SIg), and monoclonal antibodies for T and B cells (OKT3; OKT11; OKT8; OKT4; IaDR); null cells (NC) and double marker (DM) cells were also considered. "
|6.||Staphylococcal Protein A (A, Protein)IBA
|7.||Prednisone (Sone)FDA LinkGeneric
10/01/1967 - "M-components in immunoproliferative disorders. "
07/01/1990 - "Epstein-Barr virus-related sequences were detected in the spleen of a patient with infectious mononucleosis, in lung and lymph node specimens from a patient with pulmonary manifestations of infectious mononucleosis, in various tissues from seven immunosuppressed organ transplant recipients with immunoproliferative disorders, and in small biopsy specimens from a patient with nasopharyngeal carcinoma. "
|2.||Homologous Transplantation (Allograft)
|3.||Transplantation (Transplant Recipients)